Венчур Венчур Венчур Венчур
 
Венчур
 Главная
 Компания
 Услуги
 База проектов
 Проекты в реализации
  •  
  • Капсула для забора желчи
  •  
  • Неинвазивный глюкометр
     Сотрудники
     Партнеры
     Клиенты
     История успеха
     О фонде
     Регламент фонда
     Бизнес-предложение
     Как работать с фондом
     Участие в мероприятиях, публикации
     Новости, события
     FAQ
     Контакты
    Венчур
    РусскийEnglish
     

    " oney acquisition requires bravery; money saving requires common sense; money spending requires talent" - B. Averbakh"

    Non-invasive glucometer

     

    1. Company: Medical electronics Ltd. (MedEl). MedEl is a young innovation company, which was founded in 2007. Company works in the field of medical equipment. Mission: We are a team of professionals committed to understanding and satisfying the needs of all diabetics. We create valued products and services to customers in a timely and efficient manner.

     

     2. Problem at the market: Diabetes occupies the 3th place in world common sickness rate (after cardiovascular and cancer diseases). There are more than 180 M diabetics in the world. Every year total number of diabetics is increased for nearly 2%.Target market segment include people with 1-st type diebet (so-calles insulin dependent). Their total number is about 10-15% in the world. Such diabetics have to give themselves an insulin injections avery 2-3 hours. To estimate required insulin quantity they have to measure their glucose level before every injection.Current equipment (glucometers) based on chemical approach and mesure glucose level by blood sample.Many companies in the world try to solve this problem and researching new non-invaisive (painless) methods, but currently no one of them doesn't produce ready to market product.

     

    3. Product:

    The product is a portable non-invasive blood glucose measurement device, based on new optical technology.

    Key features are:

    -  Painless glucose measurement;
    -  Absolutely harmless real - time continuous measurement;
    -  Does not require any expendable materials - helps to save up to € 900 per year.

     

    4. Market

    Market segment: self - control measurement equipment for diabetics
    Consumers: 1-st and 2-d type diabetics (special consumer group include children with diabet)
    Russian market size: € 240 M
    World market size: € 15 B

     

    5. Competition:

    1. «Johnson&Johnson», USA;
    2. «Pendragon Medical», Switzerland;
    3. «Cygnus», USA.

     

    6. Management:

    Dmitry Starodubcsev - CEO
    Maria Bugaeva - Development and marketing manager
    Tatiana Ibragimova - CFO

     

    7. Financial information:

    Funding: Seeking 450 K

    Revenue:
    2010 -  K

    2011 -  K

    2012 -  K

    2013 -  K

     
    Венчур Венчур
      ГлавнаяКомпанияУслугиБаза проектовПроекты в реализацииСотрудникиПартнерыКлиентыИстория успехаБизнес-предложениеКак работать с фондомУчастие в мероприятиях, публикацииНовости, событияFAQКонтакты  
     
    Венчур Венчур © ООО "Томский центр венчурных инвестиций" © 2006 Поддержка: веб-студия R70 Венчур Венчур